# Novo Nordisk has teamed up with OpenAI to use artificial intelligence in its business.

*business · news · 2026-04-14 · Devdiscourse*

## Key points

- Novo Nordisk is partnering with OpenAI to integrate AI across its drug development operations.
- The collaboration aims to use AI to analyse complex datasets and identify promising drug candidates.
- OpenAI's technology will help Novo Nordisk boost productivity and operational speed without replacing staff.
- Novo Nordisk is leveraging AI to regain market share after Eli Lilly's recent U.S. weight-loss drug approval.

**Companies:** OpenAI, Novo Nordisk
**Countries:** Denmark, United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/technology/3873227-novo-nordisk-leverages-ai-in-weight-loss-drug-race)

---

Canonical: https://newsio.io/n/012b9417-2be5-490b-98d2-8f9625e6bc6b/novo-nordisk-has-teamed-up-with-openai-to-use-artificial-intelligence-in-its-bus
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works